You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

residual beta cell function

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 1 Diabetes Trial in Amsterdam (encapsulated autologous fecal microbiota transplantation)

Recruiting
  • Type 1 Diabetes
  • encapsulated autologous fecal microbiota transplantation
  • Amsterdam, Please Select, Netherlands
    Academisch Medisch Centrum
Apr 5, 2022

Type 1 Diabetes Trial in Worcester (Ergocalciferol, Placebo)

Completed
  • Type 1 Diabetes
  • Worcester, Massachusetts
    University of Massachusetts Medical School
Jan 9, 2022

Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)

Not yet recruiting
  • Hematologic Malignancy
  • +21 more
  • (no location specified)
Feb 9, 2023

type1diabetes, Type2diabetes, Pre Diabetes Trial in Parma (68Ga-exendin-4, mixed meal test)

Recruiting
  • type1diabetes
  • +3 more
  • Parma, Pr, Italy
    Azienda Ospedaliero Universitaria di Parma
Dec 20, 2022

Diabetes, Type 1 Trial (Ketogenic diet, food delivery and education, Standard diet, food delivery and education)

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • Ketogenic diet, food delivery and education
  • Standard diet, food delivery and education
  • (no location specified)
Jun 1, 2023

PreDiabetes Trial (Beef, Poultry)

Not yet recruiting
  • PreDiabetes
  • Beef
  • Poultry
  • (no location specified)
Jul 12, 2022

Type 1 Diabetes Trial in Indianapolis (Acetylated and Butyrylated High Amylose Maize Starch)

Recruiting
  • Type 1 Diabetes
  • Acetylated and Butyrylated High Amylose Maize Starch
  • Indianapolis, Indiana
    Indiana University School of Medicine
Aug 19, 2022

Diabetes, Type 2 Trial in San Antonio (Dapagliflozin, Exenatide, Placebo)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • San Antonio, Texas
    University of Texas Health Science Center
Sep 12, 2022

Type 1 Diabetes Trial in Shanghai (Cholecalciferol (Vit D3) 400Unit Cap)

Not yet recruiting
  • Type 1 Diabetes
  • Cholecalciferol (Vit D3) 400Unit Cap
  • Shanghai, China
    Department of Pediatrics, Ruijin Hospital, Shanghai Jiao Tong Un
May 20, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Birmingham, Alabama
  • +8 more
Jan 24, 2023

Type 1 Diabetes, Diabetes, Type 1 Trial in Australia (Abatacept (CTLA4-Ig) and nasal insulin (Humulin R®), Abatacept (CTLA4-Ig)

Recruiting
  • Type 1 Diabetes
  • Diabetes Mellitus, Type 1
  • Abatacept (CTLA4-Ig) and nasal insulin (Humulin R®)
  • Abatacept (CTLA4-Ig) and nasal placebo (0.9% sodium chloride)
  • Westmead, New South Wales, Australia
  • +5 more
Feb 15, 2023

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia Arising

Not yet recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • (no location specified)
Nov 8, 2022

Type2 Diabetes, Obesity, Morbid Trial in Hvidovre (Oral Glucose Tolerance Test, Hyperglycemic clamp with infusion of saline,

Completed
  • Type2 Diabetes
  • Obesity, Morbid
  • Oral Glucose Tolerance Test
  • Hyperglycemic clamp with infusion of saline, GLP-1 or GIP
  • Hvidovre, Denmark
    Hvidovre University Hospital
Mar 14, 2022

Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Buffalo (behavioral, drug, other)

Recruiting
  • Plasma Cell Myeloma
  • +3 more
  • Behavioral Intervention
  • +6 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 5, 2022

Prediabetes, Type 1 Diabetes Trial in Malmö (Gluten free diet, Omega 3 fatty acid, Vitamin D)

Active, not recruiting
  • Prediabetes
  • Type 1 Diabetes
  • Gluten free diet
  • +3 more
  • Malmö, Sweden
    Lund University, Department of Clinical Sciences Malmö
Oct 18, 2021

Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

Suspended
  • Juvenile Myelomonocytic Leukemia
  • +27 more
  • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2023

COVID19, BETA-CELL FUNCTION Trial in Milan (Stimulation test with arginine infusion in order to verify the possible existence of

Recruiting
  • COVID19
  • BETA-CELL FUNCTION
  • Stimulation test with arginine infusion in order to verify the possible existence of damage to the beta cell function induced by COVID-19 infection
  • Milan, MI, Italy
    Sacco University Hospital
Sep 27, 2021

Acute Myeloid Leukemia Trial (Azacitidine, Biospecimen Collection, Bone Marrow Aspirate)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
Nov 4, 2022

New-onset type1 Diabetes Trial in Worldwide (Ladarixin, Placebo)

Recruiting
  • New-onset type1 Diabetes
  • Birmingham, Alabama
  • +57 more
Nov 21, 2022

Diabetes, Type 2, Impaired Glucose Tolerance (IGT), Impaired Fasting Glucose (IFG) Trial in San Antonio (Dapagliflozin,

Recruiting
  • Diabetes Mellitus, Type 2
  • +2 more
  • San Antonio, Texas
    The University of Texas Health Science Center at San Antonio
Aug 29, 2022

Type 1 Diabetes Trial in Nijmegen (68Ga-NODAGA-Exendin-4)

Recruiting
  • Type 1 Diabetes
  • Nijmegen, Gelderland, Netherlands
    Radboud University Medical Center
Nov 17, 2022

EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type

Recruiting
  • Type1 Diabetes Mellitus
  • Beta Cell Loss and Immune Function
  • Immune Function with RNAseq
  • Hope, California
  • +3 more
Jun 1, 2022

Healthy Trial in Durham (Active Comparator: Sitagliptin, Placebo Comparator - No Sitagliptin)

Completed
Has Results
  • Healthy
  • Active Comparator: Sitagliptin
  • Placebo Comparator - No Sitagliptin
  • Durham, North Carolina
    Leslie Willis
Apr 6, 2021

Diabetes, Type 1 Trial in Warsaw (Phenofibrate, Placebo)

Recruiting
  • Diabetes Mellitus, Type 1
  • Warsaw, Mazowieckie, Poland
  • +1 more
Jun 8, 2023

Beta Cell Imaging in T1D a Different Glycemic Control

Terminated
  • Type 1 Diabetes Mellitus
  • gallium-68-exendin PET/CT
  • Nijmegen, Gelderland, Netherlands
    Radboudumc
Jan 29, 2022